As the accumulation of p53 or p16INK4a following the activation of the MAPK pathway plays a paramount role in MAPK-driven OIS, additional CDKN2A alterations are described to facilitate a senescence escape, potentially defining a particularly high-risk, low-grade glioma phenotype [79,119,120]. The gene discussed is CDKN2A; the disease is central nervous system cancer.